首页 产品目录 分子砌块 按反应类型 氨基甲酸酯合成 (4R,6R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-5',6a,8a,9-四甲基-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-二十氢螺[萘并[2',1':4,5]茚并[2,1-b]呋喃-10,2'-吡喃]-4,6-二醇

(4R,6R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-5',6a,8a,9-四甲基-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-二十氢螺[萘并[2',1':4,5]茚并[2,1-b]呋喃-10,2'-吡喃]-4,6-二醇

(4R,6R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-5',6a,8a,9-tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4,6-diol

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

874485-32-2

中文名称

(4R,6R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-5',6a,8a,9-四甲基-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-二十氢螺[萘并[2',1':4,5]茚并[2,1-b]呋喃-10,2'-吡喃]-4,6-二醇

英文名称

(4R,6R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-5',6a,8a,9-tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4,6-diol

别名

(25RS)-Ruscogenin;Spirost-5-ene-1,3-diol, (1β,3β)- (9CI);Mammalian target of Rapamycin,Inhibitor,Phosphoinositide 3-kinase,mTOR,25(R,S) Ruscogenin,inhibit,Akt,25(R,S)-Ruscogenin,PI3K,25(R,S)Ruscogenin,Protein kinase B,PKB;25(R,S)-Ruscogenin, 10 mM in DMSO;(4R,6R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-5',6a,8a,9-Tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4,6-diol

标准英文名

(4R,6R,6aR,6bS,8aS,8bR,9S,10R,11aS,12aS,12bS)-5',6a,8a,9-tetramethyl-1,3,3',4,4',5,5',6,6a,6b,6',7,8,8a,8b,9,11a,12,12a,12b-icosahydrospiro[naphtho[2',1':4,5]indeno[2,1-b]furan-10,2'-pyran]-4,6-diol

MDL No.

-

分子式

C27H42O4

分子量

430.63

精确分子量

430.31

SMILES

CC1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC=C5C[C@@H](O)C[C@@H](O)[C@]5(C)[C@H]4CC[C@]3(C)[C@H]1[C@@H]2C

标准SMILES

C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)C[C@@H](O)[C@@]43C)[C@@H]1C[C@@H]1O[C@]3(CCC(C)CO3)[C@@H](C)[C@H]21

用途

(25RS)-Ruscogenin inhibits hepatocellular carcinoma metastasis by modulating the PI3K/Akt/mTOR signaling pathway and downregulating the expression of MMP-2, MMP-9, uPA, VEGF, and HIF-1α; it also alleviates LPS-induced pulmonary endothelial cell apoptosis by inhibiting the TLR4 signaling pathway.

InChIKey

QMQIQBOGXYYATH-ZBTLHKOBSA-N

安全信息

SureRoute逆合成路线

1.  874485-32-2 逆合成路线 1

—
—
ACUYDB489
874485-32-2
来源: SureRoute

2.  874485-32-2 逆合成路线 2

—
—
ACUYDB489
874485-32-2
来源: SureRoute

3.  874485-32-2 逆合成路线 3

—
—
ACUYDB489
874485-32-2
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手